Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 600 shares, a growth of 20.0% from the June 15th total of 500 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 1.5 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY traded down $0.39 during trading hours on Tuesday, hitting $47.66. The stock had a trading volume of 298 shares, compared to its average volume of 933. The firm has a 50-day moving average price of $49.82 and a 200 day moving average price of $49.01. Hikma Pharmaceuticals has a fifty-two week low of $42.23 and a fifty-two week high of $56.63.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Recommended Stories

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.